

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Tuesday that 'ACCRUFeR', or ferric maltol, had been approv...


(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and Thursday and not separa...


(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics said on Wednesday that total net sales had grown in Q2, driven by "robu...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...